Partner Delphine Knight Brown Quoted in Law360 Article on China’s System for Drug Patent Disputes

Freeborn Partner and member of the firm's Intellectual Property Practice Team, Delphine Knight Brown, was recently quoted in a Law360 article entitled, "3 Takeaways As China Rolls Out Its Version Of ANDA Disputes." The article details key takeaways of China’s system for drug patent disputes modeled on the U.S. Hatch-Waxman Act. According to Delphine, "It's a good test case for the patent linkage system, but it doesn't test all the realities that sometimes happen with these cases, where you have multiple patents and multiple claims." To learn more or read the full article, click here.